These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7539168)

  • 1. Tissue expression of human complement inhibitor, decay-accelerating factor, in transgenic pigs. A potential approach for preventing xenograft rejection.
    Rosengard AM; Cary NR; Langford GA; Tucker AW; Wallwork J; White DJ
    Transplantation; 1995 May; 59(9):1325-33. PubMed ID: 7539168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transgenic pigs expressing human decay-accelerating factor regulated by porcine MCP gene promoter.
    Murakami H; Nagashima H; Takahagi Y; Miyagawa S; Fujimura T; Toyomura K; Nakai R; Yamada M; Kurihara T; Shigehisa T; Okabe M; Seya T; Shirakura R; Kinoshita T
    Mol Reprod Dev; 2002 Mar; 61(3):302-11. PubMed ID: 11835575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transgenic pigs expressing human CD59, in combination with human membrane cofactor protein and human decay-accelerating factor.
    Zhou CY; McInnes E; Copeman L; Langford G; Parsons N; Lancaster R; Richards A; Carrington C; Thompson S
    Xenotransplantation; 2005 Mar; 12(2):142-8. PubMed ID: 15693845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of human decay accelerating factor may protect pig lung from hyperacute rejection by human blood.
    Pierson RN; Pino-Chavez G; Young VK; Kaspar-Konig W; White DJ; Wallwork J
    J Heart Lung Transplant; 1997 Feb; 16(2):231-9. PubMed ID: 9059935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human DAF on pig cells protects against human and non-human primate sera cytotoxicity mediated by exogenous or endogenous complement, as determined by flow cytometry.
    Díaz-Román TM; Mañez R; López-Pelaez E; Centeno A; Moscoso I; Pértegaz S; Doménech N
    Transpl Immunol; 2006 Aug; 16(2):125-30. PubMed ID: 16860716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of transgenic pigs that express human decay accelerating factor and cell membrane-tethered human tissue factor pathway inhibitor.
    Lee HJ; Lee BC; Kim YH; Paik NW; Rho HM
    Reprod Domest Anim; 2011 Apr; 46(2):325-32. PubMed ID: 20626677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial expression of human decay accelerating factor in transgenic pig tissue: a potential approach for human complement inactivation in discordant xenografts.
    Rosengard AM; Cary N; Horsley J; Belcher C; Langford G; Cozzi E; Wallwork J; White DJ
    Transplant Proc; 1995 Feb; 27(1):326-7. PubMed ID: 7533400
    [No Abstract]   [Full Text] [Related]  

  • 8. Complement regulatory proteins are expressed at low levels in embryonic human, wild type and transgenic porcine neural tissue.
    Harrower TP; Richards A; Cruz G; Copeman L; Dunnett SB; Barker RA
    Xenotransplantation; 2004 Jan; 11(1):60-71. PubMed ID: 14962294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hDAF exogene protects swine endothelial and peripheral blood mononuclear cells from xenoreactive antibody mediated cytotoxicity in hDAF transgenic pigs.
    Lee JM; Tu CF; Tai HC; Chou NK; Yang TS; Weng CN; Lee YC; Lee CJ; Lee PH
    Transplant Proc; 2006 Sep; 38(7):2270-2. PubMed ID: 16980062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kidneys derived from mice transgenic for human complement blockers are protected in an in vivo model of hyperacute rejection.
    Lazzeri M; Mora M; Mulder LC; Marsicano G; Marinucci G; Boschi M; Bruzzone P; Alfani D; Cortesini R; Rossini M
    J Urol; 1998 Apr; 159(4):1364-9. PubMed ID: 9507885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful cross-breeding of cloned pigs expressing endo-beta-galactosidase C and human decay accelerating factor.
    Yazaki S; Iwamoto M; Onishi A; Miwa Y; Suzuki S; Fuchimoto D; Sembon S; Furusawa T; Hashimoto M; Oishi T; Liu D; Nagasaka T; Kuzuya T; Maruyama S; Ogawa H; Kadomatsu K; Uchida K; Nakao A; Kobayashi T
    Xenotransplantation; 2009; 16(6):511-21. PubMed ID: 20042051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The serum level of xenoantibodies, and hDAF or alphaGAL expression on pig cells, modulate in vitro the protection given by hDAF to primate complement-mediated damage.
    Díaz TM; Mañez R; Moscoso I; López D; Santamarina I; Lopez E; Centeno A; Domenéch N
    Transplant Proc; 2005; 37(1):510-1. PubMed ID: 15808692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining the hDAF transgene with the GP IIb/IIIa inhibitor tirofiban improves heart performance and reduces myocardial damage following hyperacute rejection in an ex vivo perfusion model.
    Brandl U; Erhardt M; Joeckle H; Michel S; Brenner P; Bittmann I; Roessle M; Mordstein V; Hammer C; Schmoeckel M; Reichart B
    Transplant Proc; 2005; 37(1):491-2. PubMed ID: 15808686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a CD46 transgenic pig and protection of transgenic kidneys against hyperacute rejection in non-immunosuppressed baboons.
    Loveland BE; Milland J; Kyriakou P; Thorley BR; Christiansen D; Lanteri MB; Regensburg M; Duffield M; French AJ; Williams L; Baker L; Brandon MR; Xing PX; Kahn D; McKenzie IF
    Xenotransplantation; 2004 Mar; 11(2):171-83. PubMed ID: 14962279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation between human decay-accelerating factor (hDAF) expression in pig cells and inhibition of human serum anti-pig cytotoxicity: value of highly expressed hDAF for xenotransplantation.
    Liu D; Kobayashi T; Onishi A; Furusawa T; Iwamoto M; Suzuki S; Miwa Y; Nagasaka T; Maruyama S; Kadomatsu K; Uchida K; Nakao A
    Xenotransplantation; 2007 Jan; 14(1):67-73. PubMed ID: 17214706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue expression of human decay accelerating factor, a regulator of complement activation expressed in mice: a potential approach to inhibition of hyperacute xenograft rejection.
    Cary N; Moody J; Yannoutsos N; Wallwork J; White D
    Transplant Proc; 1993 Feb; 25(1 Pt 1):400-1. PubMed ID: 7679815
    [No Abstract]   [Full Text] [Related]  

  • 17. Expression of complement regulatory proteins on islets of Langerhans: a comparison between human islets and islets isolated from normal and hDAF transgenic pigs.
    Bennet W; Björkland A; Sundberg B; Brandhorst D; Brendel MD; Richards A; White DJ; Nilsson B; Groth CG; Korsgren O
    Transplantation; 2001 Jul; 72(2):312-9. PubMed ID: 11477359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transgenic human decay accelerating factor makes normal pigs function as a concordant species.
    Schmoeckel M; Nollert G; Shahmohammadi M; Müller-Höcker J; Young VK; Kasper-König W; White DJ; Hammer C; Reichart B
    J Heart Lung Transplant; 1997 Jul; 16(7):758-64. PubMed ID: 9257258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Porcine MCP gene promoter directs high level expression of human DAF (CD55) in transgenic mice.
    Murakami H; Takahagi Y; Yoshitatsu M; Miyagawa S; Fujimura T; Toyomura K; Shigehisa T; Shirakura R; Kinoshita T
    Immunobiology; 2000 Apr; 201(5):583-97. PubMed ID: 10834315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of pigs transgenic for human decay accelerating factor.
    Langford GA; Yannoutsos N; Cozzi E; Lancaster R; Elsome K; Chen P; Richards A; White DJ
    Transplant Proc; 1994 Jun; 26(3):1400-1. PubMed ID: 7518134
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.